M4773-1G Display Image

Metaraminol (+)-bitartrate salt,

Code: M4773-1G D2-231

Application

Metaraminol (+)-bitartrate salt has been used to study the effects of adrenergic agonists in the mouse model of endometriosis.

Biochem/physiol Actio...


read more

Your Price
€90.80 1G
€111.68 inc. VAT
REQUEST

Application

Metaraminol (+)-bitartrate salt has been used to study the effects of adrenergic agonists in the mouse model of endometriosis.

Biochem/physiol Actions

α-adrenoceptor agonist.Metaraminol may serve as a false sympathetic transmitter. It is a mixed α - and β-adrenergic agonist.

Features and Benefits

This compound was developed by Merck & Co., Inc., Kenilworth, NJ, U.S.. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

1, 5 g in poly bottle

InChI keyVENXSELNXQXCNT-IJYXXVHRSA-N
InChI1S/C9H13NO2.C4H6O6/c1-6(10)9(12)7-3-2-4-8(11)5-7;5-1(3(7)8)2(6)4(9)10/h2-6,9,11-12H,10H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t6-,9-;1-,2-/m01/s1
originatorMerck & Co., Inc., Kenilworth, NJ, U.S.
Quality Level200
SMILES stringO[C@H]([C@@H](O)C(O)=O)C(O)=O.C[C@H](N)[C@H](O)c1cccc(O)c1
Cas Number33402-03-8
Hazard Class6.1
Un Number2811
Pack GroupIII
This product has met the following criteria: